JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loftus, J. C.
Right arrow Articles by Ginsberg, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loftus, J. C.
Right arrow Articles by Ginsberg, M. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 263, Issue 23, 11025-11028, 08, 1988

Alternative proteolytic processing of platelet membrane glycoprotein IIb

JC Loftus, EF Plow, LK Jennings and MH Ginsberg
Research Institute of Scripps Clinic, Department of Immunology, La Jolla, California 92037.

Platelet membrane glycoprotein (GP) IIb-IIIa is a component of a receptor for the adhesive proteins fibrinogen, fibronectin, and von Willebrand factor. GPIIb is initially synthesized as a single-chain polypeptide that is proteolytically processed to yield the two chains of mature GPIIb present on the cell surface. Analysis of the amino acid sequence surrounding the proposed light-heavy chain junction of GPIIb suggests a second potential site following a pair of basic residues 12- 15 residues upstream from the reported amino terminus of the light chain. We have utilized anti-peptide antibodies to examine the possibility of alternative cleavage at these two potential sites. Peptide V43 precedes the dibasic sequence and is known to reside in the heavy chain. Peptide V41 contains the sequence between the two potential sites. In immunoblots, anti-V43 reacted only with the heavy chain while anti-V41 reacted only with the light chain. Immunoprecipitation of surface-labeled platelets indicated 97% of the GPIIb light chain contains the V41 sequence while approximately 3% of GPIIb molecules lack the V41 sequence on both the light and heavy chains. These data indicate that GPIIb is primarily cleaved 12-15 amino acids upstream from the reported amino terminus of the light chain while in a minor proportion of GPIIb molecules cleavage occurs at both sites.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Vet PatholHome page
D. L. Lipscomb, C. Bourne, and M. K. Boudreaux
Two Genetic Defects in {alpha}IIb Are Associated with Type I Glanzmann's Thrombasthenia in a Great Pyrenees Dog: A 14-base Insertion in Exon 13 and a Splicing Defect of Intron 13
Vet. Pathol., November 1, 2000; 37(6): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Yan, D. D. Hu, S. K. Knowles, and J. W. Smith
Probing Chemical and Conformational Differences in the Resting and Active Conformers of Platelet Integrin alpha IIbbeta 3
J. Biol. Chem., March 15, 2000; 275(10): 7249 - 7260.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. M. Leisner, J. D. Wencel-Drake, W. Wang, and S. C.-T. Lam
Bidirectional Transmembrane Modulation of Integrin alpha IIbbeta 3 Conformations
J. Biol. Chem., April 30, 1999; 274(18): 12945 - 12949.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. A. Peterson, G. P. Visentin, P. J. Newman, and R. H. Aster
A Recombinant Soluble Form of the Integrin alpha IIbbeta 3 (GPIIb-IIIa) Assumes an Active, Ligand-Binding Conformation and Is Recognized by GPIIb-IIIa-Specific Monoclonal, Allo-, Auto-, and Drug-Dependent Platelet Antibodies
Blood, September 15, 1998; 92(6): 2053 - 2063.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
K. Stark, G. Yee, C. Roote, E. Williams, S Zusman, and R. Hynes
A novel alpha integrin subunit associates with betaPS and functions in tissue morphogenesis and movement during Drosophila development
Development, January 11, 1997; 124(22): 4583 - 4594.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
I. Knezevic, T. M. Leisner, and S. C.-T. Lam
Direct Binding of the Platelet Integrin alpha IIbbeta 3 (GPIIb-IIIa) to Talin. EVIDENCE THAT INTERACTION IS MEDIATED THROUGH THE CYTOPLASMIC DOMAINS OF BOTH alpha IIb AND beta 3
J. Biol. Chem., July 5, 1996; 271(27): 16416 - 16421.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Haas and E. F. Plow
The Cytoplasmic Domain of alpha[IMAGE]beta(3)
J. Biol. Chem., March 15, 1996; 271(11): 6017 - 6026.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Du, T. C. Saido, S. Tsubuki, F. E. Indig, M. J. Williams, and M. H. Ginsberg
Calpain Cleavage of the Cytoplasmic Domain of the Integrin beta(3) Subunit
J. Biol. Chem., November 3, 1995; 270(44): 26146 - 26151.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
T. O'Toole, D Mandelman, J Forsyth, S. Shattil, E. Plow, and M. Ginsberg
Modulation of the affinity of integrin alpha IIb beta 3 (GPIIb-IIIa) by the cytoplasmic domain of alpha IIb
Science, November 8, 1991; 254(5033): 845 - 847.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1988 by the American Society for Biochemistry and Molecular Biology.